|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 514.65 USD | +2.53% |
|
+6.07% | +13.52% |
| 10-15 | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653 | MT |
| 10-09 | Vertex Pharmaceuticals Says Alyftrek Delivers Pancreatic Function Recovery in Some Children | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +12.50% | - | 44,934 M€ | |
| +17.86% | - | 35,761 M€ | |
| +9.23% | - | 28 M€ | |
| +5.55% | - | 33 M€ | |
| +14.94% | - | 33 M€ | |
| +4.93% | - | 37 M€ | |
| +0.05% | - | 49 M€ | |
| +10.68% | - | 66 M€ | |
| +10.33% | - | 67 M€ | |
| +9.47% | - | 75 M€ | |
| +6.65% | - | 80 M€ | |
| +12.72% | - | 122 M€ | |
| +2.40% | - | 293 M€ | |
| +11.02% | - | 27,154 M€ | |
| +16.35% | - | 750 M€ | |
| +12.55% | - | 507 M€ | |
| +4.25% | - | 165 M€ | |
| +17.29% | - | 148 M€ | |
| +31.95% | 9.51% | 15 M€ | |
| +31.45% | 9.43% | 429 M€ | |
| +24.14% | 9.05% | 78 M€ | |
| +24.41% | 9.05% | 1,079 M€ | |
| +24.73% | 8.88% | 9,953 M€ | |
| +23.85% | 8.54% | 81 M€ | |
| +21.40% | 4.47% | 7 M€ | |
| +12.85% | 4.4% | 28 M€ | |
| +31.11% | 4.33% | 11 M€ | |
| +53.41% | 4.15% | 58 M€ | |
| +44.27% | 4.13% | 87 M€ |
Employees
6,400
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- VRTX Stock
- ETFs Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
